Inside Novo Nordisk’s Boldest Move Yet: A Weight-Loss Pill for the Masses
Daniel Gilbert, Business of Medicine Reporter at The Washington Post, breaks down Novo’s first GLP-1 weight-loss pill and why it matters.
More Videos
Are Parents Ready for Skyrocketing Childcare in 2026?
Taylor Bowley, Economist at Bank of America, details why childcare costs outpacing inflation may force tough financial trade-offs for U.S. families.
How Venezuela’s Oil Comeback Could Rewrite U.S. Energy Independence
Jay Hatfield, CEO/CIO of Infrastructure Capital Advisors, weighs in on how heavy crude may reshape U.S. refineries and energy equities.
How Retail Investors May Be Rewriting the Rules of the Market
As markets hit record highs amid volatility, eToro U.S. Head Andrew McCormick breaks down how retail investor behavior is rapidly evolving.
Exclusive: Robin Williams' Son Talks Using AI to Bring Precision to Mental Health Care
Zak Williams discusses Lumos AI and how it uses longitudinal data to match the right mental health treatment to patients sooner.
Teaching AI Responsibly: How Samsung Is Shaping Tomorrow’s Innovators
As AI becomes a core life skill, Samsung’s Allison Stransky shares how educators, students, and companies can build AI literacy responsibly.
